1028 / 1851
Stage III NSCLC: the
gap
between an
ideal patient
from the guidelines
and the
average patient
from clinical practice is especially wide
Vansteenkiste J, et al. Ann Oncol. 2013;24
|
|
1028 / 1851
Stage III NSCLC: the
gap
between an
ideal patient
from the guidelines
and the
average patient
from clinical practice is especially wide
Vansteenkiste J, et al. Ann Oncol. 2013;24